Menu
Chambers France 2025-Cécile Théard-Jallu
Chambers Pharma & Life Sciences

Cécile Théard-Jallu ranking for Pharma/Life Sciences: Regulatory in the Chambers France 2025

Awards 6 February 2025
Health law and life sciences Life sciences, health

Cécile Théard-Jallu recognized as Band 2 in the Chambers & Partners France 2025 ranking for Pharma/Life Sciences: Regulatory, highlighting the expertise and excellence of De Gaulle Fleurance & Associés in these sectors.

Cécile
Théard-Jallu
Partner
Would you like to be kept up to date with the latest news on this topic?
Sign up to receive e-mails of new articles, events, analysis... on the subjects most relevant to you.
Create your customized watch

Receive news on the topics
that matter to you

Latest news

societe-generale
Deals 18 March 2025
De Gaulle Fleurance advises the lenders on the financing of Capital Export’s acquisition of a share in Symétrie, with the support of CELDA Mezzanine
Articles 6 March 2025
Djibouti as a center for Islamic investments in the East African region
Events
13/03/202518h00
The evolution of anti-corruption in France in the last ten years : takeaways and perspectives
Chambers France 2025
Awards Propriété Intellectuelle
Chambers
De Gaulle Fleurance ranking for Intellectual Property in the Chambers Global 2025